IL300152A - Methods of treatment using furosemide - Google Patents

Methods of treatment using furosemide

Info

Publication number
IL300152A
IL300152A IL300152A IL30015223A IL300152A IL 300152 A IL300152 A IL 300152A IL 300152 A IL300152 A IL 300152A IL 30015223 A IL30015223 A IL 30015223A IL 300152 A IL300152 A IL 300152A
Authority
IL
Israel
Prior art keywords
furosemide
treatment methods
treatment
methods
Prior art date
Application number
IL300152A
Other languages
English (en)
Hebrew (he)
Inventor
John F Mohr
John Tucker
Michael Hassman
Erik Mark Pecorelli
Original Assignee
Scpharmaceuticals Inc
John F Mohr
John Tucker
Michael Hassman
Erik Mark Pecorelli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scpharmaceuticals Inc, John F Mohr, John Tucker, Michael Hassman, Erik Mark Pecorelli filed Critical Scpharmaceuticals Inc
Publication of IL300152A publication Critical patent/IL300152A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1468Containers characterised by specific material properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
IL300152A 2020-08-05 2021-08-05 Methods of treatment using furosemide IL300152A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063061518P 2020-08-05 2020-08-05
PCT/US2021/044723 WO2022031959A1 (en) 2020-08-05 2021-08-05 Methods of treatment using furosemide

Publications (1)

Publication Number Publication Date
IL300152A true IL300152A (en) 2023-03-01

Family

ID=77774970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL300152A IL300152A (en) 2020-08-05 2021-08-05 Methods of treatment using furosemide

Country Status (9)

Country Link
US (1) US20230270759A1 (https=)
EP (2) EP4192473B1 (https=)
JP (1) JP7844438B2 (https=)
CN (1) CN116322704A (https=)
AU (1) AU2021320308A1 (https=)
CA (1) CA3190585A1 (https=)
IL (1) IL300152A (https=)
MX (1) MX2023001385A (https=)
WO (1) WO2022031959A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024512650A (ja) * 2021-04-02 2024-03-19 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下注入
EP4648761A1 (en) * 2023-01-09 2025-11-19 scPharmaceuticals Inc. Methods of treatment using loop diuretics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595961B2 (en) * 2001-04-16 2003-07-22 Becton, Dickinson And Company Sterilizable transfer or storage device for medicaments, drugs and vaccines
PT2981258T (pt) * 2013-04-05 2020-10-19 Scpharmaceuticals Inc Formulações farmacêuticas para administração subcutânea de furosemida
ES3041602T3 (en) * 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof

Also Published As

Publication number Publication date
MX2023001385A (es) 2023-03-03
EP4192473A1 (en) 2023-06-14
CN116322704A (zh) 2023-06-23
EP4681736A2 (en) 2026-01-21
JP2023536730A (ja) 2023-08-29
EP4681736A3 (en) 2026-03-25
US20230270759A1 (en) 2023-08-31
EP4192473B1 (en) 2025-12-03
CA3190585A1 (en) 2022-02-10
JP7844438B2 (ja) 2026-04-13
AU2021320308A1 (en) 2023-03-02
WO2022031959A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
IL282794A (en) Therapeutic methods
DK4065585T3 (da) Substituerede makrocykliske forbindelser og relaterede behandlingsfremgangsmåder
IL285771A (en) Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
EP3813808A4 (en) Methods of treating substance abuse
IL269371A (en) Treatment methods
CL2021000047S1 (es) Masajeador.
EP3751048A4 (en) FIBER TREATMENT AGENT
EP4493175A4 (en) MIRDAMETINIB TREATMENT
EP3773633A4 (en) METHODS OF TREATMENT OF GLIOBLASTOMA
LT4034122T (lt) Hiperfenilalaninemijos gydymo būdai
EP4188608A4 (en) TREATMENT METHOD
JP1708791S (ja) マッサージ器
EP4393493A4 (en) PARP INHIBITOR-RESISTANT PATIENT TREATED WITH TH-302
IL281775A (en) Methods of treatment of infections using bacteria
EP4355238A4 (en) ELECTROPORATION TREATMENT
EP4138986C0 (en) TREATMENT DEVICE
IL300152A (en) Methods of treatment using furosemide
IL281839A (en) Treatment methods
IL281792A (en) Treatment methods
IL280968A (en) Combination therapy
EP4502348A4 (en) TREATMENT DEVICE
EP4422687A4 (en) TREATMENT DEVICE
EP4398893A4 (en) IBOGAINE COMBINATION THERAPY
EP4405465A4 (en) TREATMENT METHODS
IL270867A (en) Treatment method